BSF Enterprise Plc (LON:BSFA)
London · Delayed Price · Currency is GBP · Price in GBX 1.125
+0.273 (32.04%)
Jul 6, 2026, 5:05 PM GMT
BSF Enterprise Revenue
BSF Enterprise had revenue of 18.79K GBP in the half year ending March 31, 2026, a decrease of -65.40%. This brings the company's revenue in the last twelve months to 51.07K, up 112.02% year-over-year. In the fiscal year ending September 30, 2025, BSF Enterprise had annual revenue of 52.84K, down -8.61%.
Revenue (ttm)
51.07K
Revenue Growth
+112.02%
P/S Ratio
27.84
Revenue / Employee
3.65K
Employees
14
Market Cap
1.42M
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 52.84K | -4.98K | -8.61% |
| Sep 30, 2024 | 57.82K | 44.88K | 346.77% |
| Sep 30, 2023 | 12.94K | - | - |
| Sep 30, 2022 | - | - | - |
| Sep 30, 2021 | - | - | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Futura Medical | 1.70M |
| Oxford BioDynamics | 1.20M |
| OptiBiotix Health | 1.17M |
| Physiomics | 1.01M |
| Genflow Biosciences | 585.61K |
| CRISM Therapeutics | 231.00K |
| ValiRx | 31.37K |
| Thalia Therapeutics | 7.26K |
BSF Enterprise News
- 2 years ago - BSF Enterprise PLC Announces Participation in The ThinkEquity Conference - Newsfile Corp
- 3 years ago - BSF Enterprise PLC Provides City-MixTM Bio-Pharmaceutical Update - GlobeNewsWire